Market Cap (In CNY)
2.04 Billion
Revenue (In CNY)
517.83 Million
Net Income (In CNY)
36.31 Million
Avg. Volume
2.4 Million
- Currency
- CNY
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 12.68-27.93
- PE
- 48.71
- EPS
- 0.35
- Beta Value
- 0.198
- ISIN
- CNE100002F44
- CUSIP
- -
- CIK
- -
- Shares
- 120000000.0
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Yuping Cao
- Employee Count
- -
- Website
- https://www.hicin.cn
- Ipo Date
- 2017-01-12
- Details
- Nanjing Hicin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, marketing, and sale of pharmaceutical preparations and synthetic chemicals in China. The company offers antivirals, antibiotics, endocrine drugs, gastrointestinal drugs, orthopedic drugs, drugs for cardio-cerebral system, and immuno-modulate agents. It also provides technical transferring services. The company also exports APIs; omeprazole sodium and cefepime hydrochloride for injections; and lansoprazole tablets to South-Asian countries, South-American countries, and European countries. Nanjing Hicin Pharmaceutical Co., Ltd. was founded in 2003 and is based in Nanjing, China.
More Stocks
-
ASCASOS Plc
ASC
-
BIAFW
-
000679
-
SURRY
-
GOEVWCanoo Holdings Ltd.
GOEVW
-
XFLS
-
SNST
-
BZ